CO5251449A1 - N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido - Google Patents

N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido

Info

Publication number
CO5251449A1
CO5251449A1 CO00093231A CO00093231A CO5251449A1 CO 5251449 A1 CO5251449 A1 CO 5251449A1 CO 00093231 A CO00093231 A CO 00093231A CO 00093231 A CO00093231 A CO 00093231A CO 5251449 A1 CO5251449 A1 CO 5251449A1
Authority
CO
Colombia
Prior art keywords
spacer
atoms
trimetilfenil
pentasacose
methylbenzenocarboximidamida
Prior art date
Application number
CO00093231A
Other languages
English (en)
Spanish (es)
Inventor
Van Boeckel Constan Adri Anton
Cornelia Maria Tromp
Geertsen Tamara Theodora Maria
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of CO5251449A1 publication Critical patent/CO5251449A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CO00093231A 1999-12-07 2000-12-06 N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido CO5251449A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204172 1999-12-07

Publications (1)

Publication Number Publication Date
CO5251449A1 true CO5251449A1 (es) 2003-02-28

Family

ID=8240976

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00093231A CO5251449A1 (es) 1999-12-07 2000-12-06 N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido

Country Status (23)

Country Link
US (1) US6875755B2 (https=)
EP (1) EP1237897B1 (https=)
JP (1) JP4820517B2 (https=)
KR (1) KR100776607B1 (https=)
CN (1) CN1195767C (https=)
AR (1) AR026726A1 (https=)
AU (1) AU781846B2 (https=)
BR (1) BR0016217A (https=)
CA (1) CA2393042C (https=)
CO (1) CO5251449A1 (https=)
CZ (1) CZ303385B6 (https=)
HK (1) HK1047593A1 (https=)
HU (1) HUP0203471A3 (https=)
IL (2) IL149628A0 (https=)
NO (1) NO323059B1 (https=)
NZ (1) NZ519100A (https=)
PE (1) PE20010935A1 (https=)
PL (1) PL202840B1 (https=)
RU (1) RU2266913C2 (https=)
SK (1) SK287682B6 (https=)
TW (1) TWI289566B (https=)
WO (1) WO2001042262A2 (https=)
ZA (1) ZA200203799B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2423888T3 (es) * 2001-09-07 2013-09-25 Alchemia Limited Pentasacáridos de heparina sintéticos
US7208498B2 (en) 2002-07-15 2007-04-24 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
ATE370141T1 (de) 2002-10-07 2007-09-15 Merck & Co Inc Antidiabetische heterocyclische beta- aminoverbindungen als inhibitoren von dipeptidylpeptidase
EP1562925B1 (en) 2002-11-07 2007-01-03 Merck & Co., Inc. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004064778A2 (en) 2003-01-17 2004-08-05 Merck & Co. Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004069162A2 (en) 2003-01-31 2004-08-19 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004103276A2 (en) 2003-05-14 2004-12-02 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004110436A1 (en) 2003-06-06 2004-12-23 Merck & Co., Inc. Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
CN1809544A (zh) 2003-06-17 2006-07-26 麦克公司 作为二肽基肽酶抑制剂用于治疗或预防糖尿病的环己基甘氨酸衍生物
AU2004261186A1 (en) 2003-07-31 2005-02-10 Merck & Co., Inc. Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
ATE500849T1 (de) * 2005-10-10 2011-03-15 Organon Nv Antikoagulans/antithrombose-dual-hemmer mit einem biotin-label
BR112012015016B8 (pt) 2009-12-18 2021-05-25 Catalent France Beinheim Sa formulação farmacêutica, forma de dosagem farmacêutica entérica e uso de uma formulação

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) * 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
IL126893A (en) * 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
US6486129B1 (en) * 1998-06-17 2002-11-26 Akzo Nobel N.V. Antithrombotic compounds

Also Published As

Publication number Publication date
CA2393042A1 (en) 2001-06-14
ZA200203799B (en) 2003-10-29
JP4820517B2 (ja) 2011-11-24
CZ303385B6 (cs) 2012-08-29
JP2003520208A (ja) 2003-07-02
SK287682B6 (sk) 2011-06-06
HUP0203471A3 (en) 2003-03-28
CA2393042C (en) 2011-06-28
NO323059B1 (no) 2006-12-27
KR100776607B1 (ko) 2007-11-16
TWI289566B (en) 2007-11-11
CZ20021958A3 (cs) 2002-08-14
RU2266913C2 (ru) 2005-12-27
NO20022689L (no) 2002-06-06
PL355484A1 (en) 2004-05-04
CN1407989A (zh) 2003-04-02
EP1237897B1 (en) 2015-01-14
HK1047593A1 (zh) 2003-02-28
WO2001042262A2 (en) 2001-06-14
SK7942002A3 (en) 2002-09-10
AU2003801A (en) 2001-06-18
IL149628A (en) 2010-04-29
US20030114361A1 (en) 2003-06-19
AU781846B2 (en) 2005-06-16
NZ519100A (en) 2004-09-24
EP1237897A2 (en) 2002-09-11
CN1195767C (zh) 2005-04-06
KR20020070988A (ko) 2002-09-11
NO20022689D0 (no) 2002-06-06
PL202840B1 (pl) 2009-07-31
AR026726A1 (es) 2003-02-26
WO2001042262A3 (en) 2001-12-13
BR0016217A (pt) 2002-09-10
US6875755B2 (en) 2005-04-05
IL149628A0 (en) 2002-11-10
HUP0203471A2 (hu) 2003-02-28
PE20010935A1 (es) 2001-09-20

Similar Documents

Publication Publication Date Title
CO5251449A1 (es) N-(aminocarbonil)-2-{[(4-metoxi-2,3,6-trimetilfenil)sulfonil]amino}-piperidinil- carboxamida-methylbenzenocarboximidamida con un espaciador de 13 a 25 atomos, unido a un pentasacarido
TR199901528T2 (xx) Viral enfeksiyonlar ve kanser tedavisinde benzimidazol-2-karbamatlar�n kullan�m�.
CA2197672A1 (en) Tetrahydrofuran antifungals
KR960007545A (ko) 합성 흥분성 아미노산
GEP20043241B (en) Compounds for Treatment of Ischemia and Pharmaceutical Compositions Containing the Same
PT1326634E (pt) Composicao de vacina compreendendo um antigenio e um peptido possuindo propriedades adjuvantes
TW200730540A (en) Novel peptide compounds
CO5251429A1 (es) Derivados de ter-butil-(7-metil-imidazo(1,2-a)piridin-3- il)-amina procedimiento para su preparacion, medicamentos que los contienen, su uso para la preparacion de un medicamento para la inhibicion de la no-sintasa y composiciones farmaceuticas que l
PL332725A1 (en) Pharmaceutic compounds
BR9907962A (pt) Composição farmacêntica, composto, e, processo para preparar o mesmo
CO5310550A1 (es) Nuevo derivado de androstano antiinflamatorio, su polimorfo, sus formas cristalinas solvatadas, composiciones farmaceutias, proceso para prepararlo, intermediario
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
DE69615808D1 (de) Camphothecinderivate
BR9507561A (pt) Ligação de E-selectina P-selectina ou L-selectina para sialil-lewis X ou sialil-lewis A
CO5271666A1 (es) Derivados de pirimidina
AR043929A1 (es) Fases cristalinas de un inhibidor del hcv
CO5251427A1 (es) Oxazolidinonas que tienen la fucion de sulfoximina
EP1108427A3 (en) Compositions for and uses thereof for altering gene expression with phenylacetate and derivatives thereof
KR910009712A (ko) 세펨 화합물 및 이의 제조방법
CL2004001050A1 (es) Compuesto derivado de 3'-[4-oxo-3-{[(ciclopropil o 2,2,2-trifluoroetil)amino]carbonil}-1,8-naftiridin-1(4h)-il]-3-sustituido-1-1'-bifenil-4-il; composicion farmaceutica; y uso en el tratamiento o prevencion de asma, bronquitis cronica, enfermedad pul
RU2002118117A (ru) Антитромботическое соединение
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
CO4990974A1 (es) Un derivado carbohidrato
ES2130257T3 (es) Nuevos compuestos y conjugados.
CO5090837A1 (es) Derivados de 1,3,4-oxadiazolona

Legal Events

Date Code Title Description
FG Application granted
FD Application lapsed